Tetsuo Oka

2.4k total citations
117 papers, 2.1k citations indexed

About

Tetsuo Oka is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Tetsuo Oka has authored 117 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 49 papers in Cellular and Molecular Neuroscience and 17 papers in Physiology. Recurrent topics in Tetsuo Oka's work include Neuropeptides and Animal Physiology (29 papers), Receptor Mechanisms and Signaling (25 papers) and Neuroscience and Neuropharmacology Research (17 papers). Tetsuo Oka is often cited by papers focused on Neuropeptides and Animal Physiology (29 papers), Receptor Mechanisms and Signaling (25 papers) and Neuroscience and Neuropharmacology Research (17 papers). Tetsuo Oka collaborates with scholars based in Japan, United States and Singapore. Tetsuo Oka's co-authors include Atsushi Hashimoto, Eikichi Hosoya, Kazuko Aoki, Mitsuaki Suda, Teruhiko Matsumiya, Akira Furuya, Ryoichi Katsumata, Akio Ozaki, Masanobu Yoshikawa and Toyokazu Hiranuma and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Tetsuo Oka

113 papers receiving 2.0k citations

Peers

Tetsuo Oka
Amos Neidle United States
M. Tardy France
Otto Z. Sellinger United States
J Axelrod United States
John Guastella United States
Michael W. J. Cleeter United Kingdom
Bradley C. Wise United States
Oh‐Shin Kwon South Korea
S. Colette Daubner United States
Amos Neidle United States
Tetsuo Oka
Citations per year, relative to Tetsuo Oka Tetsuo Oka (= 1×) peers Amos Neidle

Countries citing papers authored by Tetsuo Oka

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Oka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Oka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Oka more than expected).

Fields of papers citing papers by Tetsuo Oka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Oka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Oka. The network helps show where Tetsuo Oka may publish in the future.

Co-authorship network of co-authors of Tetsuo Oka

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Oka. A scholar is included among the top collaborators of Tetsuo Oka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Oka. Tetsuo Oka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kurozumi, Kazuhiko, Yoshihiro Otani, Atsuhito Uneda, et al.. (2022). Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis. PLoS ONE. 17(8). e0273242–e0273242. 3 indexed citations
3.
Tomita, Yusuke, Kazuhiko Kurozumi, Ji Young Yoo, et al.. (2019). Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways. Molecular Cancer Therapeutics. 18(8). 1418–1429. 27 indexed citations
4.
Shimizu, Toshihiko, Joji Ishida, Kazuhiko Kurozumi, et al.. (2019). δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion. Molecular Cancer Therapeutics. 18(4). 812–822. 15 indexed citations
5.
Yoshikawa, Masanobu, Takashi Shinomiya, Hideo Tsukamoto, et al.. (2008). Long-Term Treatment With Morphine Increases the D-Serine Content in the Rat Brain by Regulating the mRNA and Protein Expressions of Serine Racemase and D-Amino Acid Oxidase. Journal of Pharmacological Sciences. 107(3). 270–276. 17 indexed citations
6.
Yoshikawa, Masanobu, et al.. (2008). Great Increase in Antinociceptive Potency of [Leu5]Enkephalin After Peptidase Inhibition. Journal of Pharmacological Sciences. 106(2). 295–300. 11 indexed citations
7.
Yoshikawa, Masanobu, Kenji Ito, Miho Maeda, et al.. (2007). Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats. European Journal of Pharmacology. 565(1-3). 89–97. 14 indexed citations
8.
Yoshikawa, Masanobu, Kazuyuki Nakajima, Setsuko Noda, et al.. (2006). Expression of the mRNA and protein of serine racemase in primary cultures of rat neurons. European Journal of Pharmacology. 548(1-3). 74–76. 24 indexed citations
9.
Hashimoto, Atsushi, Masanobu Yoshikawa, Hiroshi Yano, et al.. (2006). Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the d-serine levels in rat brain. European Journal of Pharmacology. 555(1). 17–22. 17 indexed citations
10.
Midoro‐Horiuti, Terumi, Catherine H. Schein, Venkatarajan S. Mathura, et al.. (2005). Structural basis for epitope sharing between group 1 allergens of cedar pollen. Molecular Immunology. 43(6). 509–518. 31 indexed citations
11.
Yoshikawa, Masanobu, Tetsuo Oka, Mitsuru Kawaguchi, & Atsushi Hashimoto. (2004). MK-801 upregulates the expression of d-amino acid oxidase mRNA in rat brain. Molecular Brain Research. 131(1-2). 141–144. 22 indexed citations
12.
Kanai, Masayuki, et al.. (2002). [Met5]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors. European Journal of Pharmacology. 453(1). 53–58. 11 indexed citations
13.
Liu, Xiaofei, et al.. (1995). The in vitro and in vivo resistance of synthetic enkephalin analogs to three enkephalin-hydrolyzing enzymes. Regulatory Peptides. 59(1). 87–96. 2 indexed citations
14.
Mizukami, Toru, et al.. (1994). Cloning of the ATP Phosphoribosyl Transferase Gene ofCorynebacterium glutamicumand Application of the Gene toL-Histidine Production. Bioscience Biotechnology and Biochemistry. 58(4). 635–638. 21 indexed citations
15.
Shinohara, Kazuyuki & Tetsuo Oka. (1994). Protein synthesis inhibitor phase shifts vasopressin rhythms in long-term suprachiasmatic cultures. Neuroreport. 5(16). 2201–2204. 4 indexed citations
16.
Oka, Tetsuo, et al.. (1993). Enkephalin-inactivating enzymes.. Folia Pharmacologica Japonica. 101(4). 197–207. 5 indexed citations
17.
Oka, Tetsuo, et al.. (1992). Effects of the subcutaneous administration of enkephalins on tail-flick response and righting reflex of developing rats. Developmental Brain Research. 69(2). 271–276. 14 indexed citations
18.
Itoh, Seiga, Tamio Mizukami, Tadashi Matsumoto, et al.. (1984). Efficient Expression in Escherichia coli of a Mature and a Modified Human Interferon-β 1. DNA. 3(2). 157–165. 23 indexed citations
19.
Watanabe, Yasuo, et al.. (1979). Effects of 5, 7-Dihydroxytryptamine on Brain Monoamine Contents and on Morphine-Induced Hypothermia in Rats. 4(4). 323–330. 1 indexed citations
20.
Takemori, A.E., et al.. (1973). ALTERATION OF ANALGESIC RECEPTORANTAGONIST INTERACTION INDUCED BY MORPHINE. Journal of Pharmacology and Experimental Therapeutics. 186(2). 261–265. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026